ACT001通过抑制NF-κB/NLRP3信号通路来改善OVX诱导的骨质疏松症
Yuan Li1, Jin-Yu Yang1, Ma-Li Lin1
1State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, College of Pharmaceutical Sciences, Hebei University, Baoding, 071002, China.
Molecular medicine (Cambridge, Mass.)
|April 8, 2025
概括
通过抑制NF-κB/NLRP3通路,ACT001有效地抑制骨质细胞分化,并减少骨质疏松症模型中的骨质损失. 这表明ACT001是ACT001.
科学领域:
- 骨生物学和疾病
- 药理学和药物发现
- 免疫学和炎症 免疫学和炎症
背景情况:
- 骨质疏松症 (OP) 是一种代谢性骨病,其特征是骨质减少和骨质细胞活性增加.
- 美国食品和药物管理局批准的孤儿药物ACT001具有组织保护作用,但其对骨质细胞分化和机制的影响尚不清楚.
研究的目的:
- 调查ACT001在防止骨质细胞分化中的作用,并阐明其潜在机制.
- 评估ACT001在雌激素缺乏引起的骨损失中的治疗潜力.
主要方法:
- 在实验室中评估ACT001对RANKL诱导的骨质细胞分化,基因表达 (Nfatc1,TRAP,Ctsk,Dc-stamp) 和热致死标记物的影响.
- 使用卵巢切除诱导的骨质疏松症小鼠模型进行体内研究,以评估骨损失,骨质细胞数量和炎症标志物 (NLRP3,IL-1β).
- 与NLRP3炎症酶抑制剂MCC950.0进行比较分析.
主要成果:
- 在没有细胞毒性的情况下,ACT001在体外抑制了RANKL诱导的骨质细胞分化和F-actin环形成.
- ACT001抑制了NF-κB酸化和NLRP3炎症酶激活,降低了与热死相关的蛋白质表达.
- 在小鼠中,ACT001治疗保护了卵巢切除诱导的骨损失,减少了骨质细胞数量,并降低了NLRP3和IL-1β的表达.
结论:
- ACT001通过抑制NF-κB/NLRP3通路来抑制骨质细胞分化.
- 在雌激素缺乏模型中,ACT001减轻了骨损失,突出了其在治疗骨质疏松症和维持骨质稳定方面的潜力.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
414
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
11.6K
相关概念视频
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
01:31Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
01:17Hormones and Bone Tissue
2.5K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.5K
01:40Bone Remodeling
38.0K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.0K
01:25Role of Vitamins in Maintaining Bone Health
3.1K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.1K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K